Tracheostomy - Nursing Case Study
Pathophysiology
• Primary mechanism: A tracheostomy involves creating an opening in the trachea to bypass upper airway obstructions, allowing direct access for ventilation. This procedure is crucial when the upper airway is compromised due to conditions such as tumors, trauma, or prolonged intubation.
• Secondary mechanism: The tracheostomy tube maintains patency of the airway and helps in the removal of secretions, reducing the risk of aspiration and improving pulmonary hygiene. It also facilitates mechanical ventilation by providing a stable airway.
• Key complication: Infection at the stoma site is a moderate complication due to the direct communication between the external environment and the lower respiratory tract, requiring vigilant care to prevent serious infections like tracheitis or pneumonia.
Patient Profile
Demographics:
58-year-old female, retired teacher
History:
• Key past medical history: Chronic obstructive pulmonary disease (COPD), hypertension, diabetes mellitus type 2
• Current medications: Lisinopril 10 mg daily, Metformin 500 mg twice daily, Albuterol inhaler as needed, Aspirin 81 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Difficulty breathing and increased secretions from tracheostomy site
• Key symptoms: Shortness of breath, wheezing, productive cough with yellow sputum, mild fever, fatigue
• Vital signs: Temperature 100.4°F, Heart rate 108 bpm, Respiratory rate 24 breaths per minute, Blood pressure 145/92 mmHg, SpO2 88% on room air
Section 1
As the healthcare team conducts an initial assessment, they find that the patient exhibits increased work of breathing and the use of accessory muscles, indicating respiratory distress. Auscultation of the lungs reveals bilateral wheezing and diminished breath sounds in the lower lobes, suggesting airway obstruction and potential consolidation. The tracheostomy site shows signs of mild erythema and increased purulent discharge, raising concerns for localized infection. The patient's SpO2 remains low at 88% on room air, even after positioning and secretion clearance attempts.
To further investigate the patient's condition, a chest X-ray is ordered, revealing opacities in the right lower lobe consistent with pneumonia. A culture of the tracheal secretions is taken to identify any bacterial pathogens, with initial results indicating gram-positive cocci, suggestive of a possible staphylococcal infection. Blood tests show leukocytosis with a white blood cell count of 14,000/mm³ and elevated C-reactive protein, both indicative of an inflammatory response. Despite initiating supplemental oxygen via a humidified tracheostomy collar, the patient's SpO2 only improves marginally to 91%, prompting consideration for antibiotic therapy to address the suspected infection.
In response to these findings, the medical team initiates broad-spectrum antibiotics while awaiting culture sensitivities to tailor therapy specifically. The patient's respiratory status is closely monitored, with plans to escalate respiratory support if necessary. This scenario requires careful consideration of the balance between managing the infection and addressing the underlying COPD exacerbation, highlighting the importance of integrating clinical reasoning to optimize the patient's respiratory function while minimizing further complications.
Section 2
As the healthcare team continues to manage the patient's condition, they notice a change in the patient's status. Over the next 24 hours, despite the initiation of broad-spectrum antibiotics, the patient begins to exhibit signs of increasing respiratory distress. The respiratory rate elevates to 32 breaths per minute, and there is more pronounced use of accessory muscles. The patient appears anxious and is unable to speak in full sentences, indicating significant respiratory compromise. A repeat auscultation of the lungs now reveals more pronounced wheezing throughout and decreased air movement, particularly in the right lung. The SpO2 levels fluctuate between 86% to 89% despite the supplemental oxygen, suggesting that the current respiratory support may be inadequate.
To address these developments, the medical team conducts an arterial blood gas (ABG) analysis, revealing a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicating acute respiratory acidosis secondary to hypoventilation. These results reflect an inadequate gas exchange and worsening of the underlying COPD exacerbation. The team also notes an increasing heart rate at 110 beats per minute and a blood pressure of 150/95 mmHg, potentially indicating a compensatory response to hypoxia. Given the patient's declining respiratory status, the team considers escalating respiratory support, possibly transitioning to non-invasive ventilation or even mechanical ventilation, to stabilize the patient's oxygenation and ventilation while continuing aggressive treatment for the suspected pneumonia.
This situation highlights the necessity for the healthcare team to integrate clinical reasoning by continuously reassessing the patient's response to interventions. It is crucial to balance the management of the respiratory infection with the exacerbation of COPD, ensuring that the respiratory support is adequate to prevent further deterioration. The team must also anticipate potential complications such as respiratory failure and the need for more invasive support, making timely and informed decisions based on the evolving clinical picture.
Section 3
As the medical team proceeds with their plan, they decide to initiate non-invasive ventilation (NIV) via a BiPAP machine to enhance the patient's ventilation and improve gas exchange. Within the first hour of initiating NIV, the patient shows a slight improvement in respiratory rate, which decreases to 28 breaths per minute. However, despite this intervention, the patient continues to exhibit significant use of accessory muscles, and the SpO2 levels remain precarious, only marginally improving to 90-92%. A repeat arterial blood gas analysis shows a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 65 mmHg, indicating partial improvement in ventilation but persisting respiratory acidosis.
Simultaneously, the patient starts to develop a productive cough with thick, greenish sputum, raising concerns about the effectiveness of the current antibiotic regimen. The medical team decides to obtain a sputum culture to better identify the causative organism and adjust antibiotic therapy accordingly. Additionally, a chest X-ray is performed, which reveals an area of consolidation in the right lower lobe, consistent with the suspected pneumonia, and the possibility of developing atelectasis is considered due to the decreased air movement previously noted in the right lung.
The patient's heart rate continues to hover around 108 beats per minute, and the blood pressure remains elevated at 148/92 mmHg, suggesting continued cardiovascular stress. Given the partial response to non-invasive ventilation and the emergence of these new findings, the team contemplates the potential necessity of transitioning to mechanical ventilation if the patient's condition does not stabilize soon. This highlights the importance of timely reassessment and the need for potential escalation in respiratory support, alongside ongoing management of the infection and COPD exacerbation.
Section 4
New Complications
As the medical team reviews the patient's current status, it becomes apparent that the persistent use of accessory muscles and the marginal improvement in SpO2 are concerning. Within the next few hours, the patient's respiratory effort visibly increases, with a respiratory rate now fluctuating between 30-32 breaths per minute. The increased work of breathing is accompanied by audible wheezing and the patient reports feeling more fatigued, suggesting an exacerbation of the underlying COPD. Despite the administration of bronchodilators and corticosteroids, the respiratory distress continues to escalate, and the patient begins to exhibit signs of increased anxiety, further complicating the clinical picture.
The results from the sputum culture return, indicating the presence of Pseudomonas aeruginosa, a resistant organism known for complicating respiratory infections, particularly in those with chronic lung disease. This finding prompts an immediate reassessment of the antibiotic regimen, leading to the initiation of a more targeted antibiotic therapy aimed at effectively tackling the resistant strain. However, the antibiotic change takes time to exert its full effect, during which the patient's condition remains tenuous.
As the team monitors the situation, the patient's cardiovascular status also shows signs of deterioration. The heart rate increases to 115 beats per minute, and blood pressure rises slightly to 152/94 mmHg, indicating a potential strain on the cardiovascular system. The combination of respiratory distress and cardiovascular stress raises the risk of further complications, such as acute respiratory failure or cardiac compromise. The team is now faced with the critical decision of whether to escalate to invasive mechanical ventilation to stabilize the patient's respiratory status, while also addressing the infectious process and managing the exacerbation of COPD symptoms. This scenario underscores the need for a comprehensive approach that balances immediate interventions with long-term management strategies.
Section 5
The medical team decides to proceed with a comprehensive reassessment of the patient's condition to guide their next steps. During the initial assessment, the patient's vital signs are closely monitored, revealing a persistent tachycardia with a heart rate of 120 beats per minute. The blood pressure remains elevated at 154/96 mmHg, and the respiratory rate continues to fluctuate between 32-34 breaths per minute, underscoring the severity of the respiratory distress. Upon auscultation, the wheezing is more pronounced, and diminished breath sounds are noted in the lower lobes, suggesting possible atelectasis or further obstruction. The SpO2 remains suboptimal at 88% on high-flow oxygen, indicating a potential need for more aggressive respiratory support.
Laboratory results show a rising white blood cell count, now at 15,000/mm³, reflecting a systemic response to infection. Arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg, confirming respiratory acidosis and hypoxemia. The chest X-ray performed reveals increased infiltrates in the right lower lobe, aligning with the clinical suspicion of worsening pneumonia due to Pseudomonas aeruginosa. These findings raise concerns about the progression to acute respiratory failure, necessitating an urgent reassessment of the patient's treatment plan.
In response, the team considers transitioning to invasive mechanical ventilation to prevent further respiratory compromise. Discussions focus on the balance between stabilizing the patient's respiratory function and managing the underlying infection. Additionally, adjustments to the bronchodilator regimen are made to optimize airway patency, and the new antibiotic therapy is closely monitored for efficacy. The team also implements measures to address the patient's anxiety, recognizing its impact on respiratory effort and overall condition. As these interventions are initiated, the team remains vigilant, anticipating potential complications and adapting the care plan accordingly to guide the patient toward recovery.